Venus Medtech (启明医疗) & Peijia Medical (沛嘉医疗) Placement - Take Your Pick
Venus MedTech (2500 HK) is looking to raise up to US$187m in its primary placement. At the same time, Peijia Medical (9996 HK) is looking to raise...
397 Views
MicroPort CardioFlow IPO Initiation: To Save a Life
MicroPort is pre-marketing for an HK IPO to raise $300 million. With a large addressable market opportunity and VitaFlow’s potentially best-in...
858 Views
MicroPort Cardioflow (微创心通) Pre-IPO: Strong Sales Ramp-Up Despite Being Late in Market
The company's first-generation TAVR, VitaFlow, has decent clinical data in terms of efficacy and safety. It was launched two years behind VenusA...
402 Views
China Healthcare Weekly (Jan.8)
The article analyzed the viewpoints in neurointerventional medical devices market, orthokeratology lenses market and pet medical market in China,...
228 Views
Microport Cardioflow: Winning in TAVR
We provide our initial thoughts on the proposed listing of medical device (TAVR) company MicroPort Cardioflow on the HKEX.
368 Views